Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Pregabalin dependence: Experiences from liaison psychiatric settings in Kashmir, North India: A case series

Ind Psychiatry J. 2025 Jan-Apr;34(1):114-116. doi: 10.4103/ipj.ipj_474_24. Epub 2025 Apr 18.

ABSTRACT

Pregabalin, a gamma-aminobutyric acid (GABA) analog, is a new-generation antiepileptic that is approved for the treatment of neuropathic pain, fibromyalgia, partial seizures, and generalized anxiety disorder. There is a rising concern regarding its abuse potential, and a handful of case reports have highlighted the same. We present a case series on pregabalin dependence. In contrast to previous case reports, which focused on patients with a history of illicit drug abuse, we present cases of drug-naïve individuals for whom pregabalin was the first substance of abuse. The highlight of the study is that we describe cases of pregabalin intoxication and a rare case of pregabalin withdrawal, which presented as a lethal suicidal attempt to liaison psychiatric settings.

PMID:40376629 | PMC:PMC12077636 | DOI:10.4103/ipj.ipj_474_24

Document this CPD

AI-Assisted Evidence Search

Share Evidence Blueprint

QR Code

Search Google Scholar

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review (RAISR4D)